Quest Diagnostics Incorporated
DGX
NYSE·Healthcare·Medical - Diagnostics & Research·Mkt cap $26.2B
$237.14
▼ -0.94%
P/E
25.07
Mkt Cap
$26.2B
52-Wk Range
$171.18–$247.19
52-Week Range
$171.18 - $247.19
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 29.9% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Extensive Laboratory Network
- Comprehensive Diagnostic Testing Portfolio
- Advanced Information Technology Infrastructure
- Strong Relationships with Healthcare Providers
Bear Case
1 risk
- Low volatility (beta 0.5).
Growth
Stable outlook
Increasing Healthcare Diagnostic Needs
Value
Attractively priced below Life Sciences Tools peer average
Momentum
Hot
+20.3% over 3m
Quality
Stable
Excellent business quality
Dividend
Modest
1.40% yield
Smart-money signal
Who's buying DGX right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 20, 2026
JUL 23, 2026
Reported EPS of $3.12 vs $2.82 consensus (+10.6% surprise). Revenue of $3.0B vs $3.0B expected (+2.4%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+10.6%
Revenue trend · last 8Q
—
+15%
+12%
+15%
+13%
+7%
+9%
+10%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$2.5B
$2.6B
$2.7B
$2.8B
$2.8B
$2.8B
$2.9B
$3.0B
Margins · last 8Q
Gross
33.8%
Operating
15.1%
Profit
10.5%
Wall Street consensus
5 analysts · 20% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
20%
Hold
80%
Sell
0%
Median Price Target
—
Latest: UBS · Jul 24, 2026
vs Industry
How DGX stacks vs Medical - Diagnostics & Research
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related